Structured evidence table for Caffeine Recovery Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Caffeine Recovery Randomized Trial | All participants met the classification of being Tier 2 athletes [], and habitual caffeine use was chosen to minimize the risk of adverse events from unaccustomed caffeine intake. | 4 | Pavis George F. (2026) | An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists |
| Caffeine Recovery Randomized Trial | From baseline, plasma caffeine concentration remained unchanged with PLA throughout SS, but was elevated by CB immediately prior to, and at 10, 20 and 30 mins of SS (interaction < 0.001; all timepoints increased from baseline, and greater than PLA; post hoc < 0.001). | 4 | Pavis George F. (2026) | An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists |
| Caffeine Recovery Randomized Trial | However, plasma caffeine further increased from 0 to 4 h of recovery with CB (interaction < 0.001; all timepoints within 4 h increased, and greater than PLA; post hoc < 0.01). | 4 | Pavis George F. (2026) | An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists |
| Caffeine Recovery Randomized Trial | 1–3 4 5 6 Coffea arabica Caffeine-containing supplements are among the most commonly used nutritional supplements by recreational and elite athletes, optimizing exercise performance and/or reducing effort perception []. | 4 | Pavis George F. (2026) | An extract from whole Coffea arabica coffee cherry improves time trial performance, but not muscle glycogen resynthesis, in trained cyclists |
Source documents